Teva Pharmaceuticals will sell a generic copy of Mylan’s EpiPen, which became the target of public outrage over its price. The F.D.A. says the shortage of the lifesaving device is ‘short-term ...

Europe’s regulator has called for generic medicines from manufacturers including Novartis’ Sandoz unit, Teva and Mylan to be pulled from the market, after US inspectors found evidence that ...

Mylan’s long-awaited rival for Teva’s blockbuster multiple sclerosis drug Copaxone has been approved in the US, putting a large chunk of the Israeli firm’s revenues at risk. The timing could ...

MS experts are recommending updates to the 2017 McDonald diagnostic criteria that aim to make diagnosis easier, faster and more accurate.

Teva's reasonable valuation, an improving pipeline and the prospect of growth in sales and profits are good enough reasons for those who own the stock to stay invested. TEL AVIV, Israel, Sept. 11 ...

Key driver of the global onychomycosis market is the increasing prevalence of risk factors such as diabetes, aging population, weakened immune systems, and nail trauma.Westford, USA, Sept. 18, 2024 ...

Medication patches are available in a limited number of dosage strengths. Occasionally, some patients require a different dosage of a medication than the dosages commercially available in patch ...

The global postoperative pain market is set to experience remarkable expansion, with projections indicating it will surpass ...